Research Article
Prevalence, Clinical Presentation, and Outcome of Tuberculosis in Patients with Chronic Kidney Disease at a Tertiary Care Hospital in Nepal
Table 8
Factors affecting outcomes of TB patients at two months of starting ATT.
| Parameters | Improved (%) | Not improved (%) | Mortality (%) | Lost to follow-up (%) | Total |
| Duration of symptoms before TB diagnosis | | | | | | <2 weeks | 5 (41.7) | 2 (16.7) | 4 (33.3) | 1 (8.3) | 12 | ≥2 weeks | 24 (64.9) | 2 (5.4) | 10 (27) | 1 (2.7) | 37 |
| CKD stage | | | | | | Stage 3 | 2 (66.7) | 0 (0) | 1 (33.3) | 0 (0) | 3 | Stage 4 | 3 (42.9) | 0 (0) | 4 (57.1) | 0 (0) | 7 | Stage 5 | 4 (50) | 0 (0) | 3 (37.5) | 1 (12.5) | 8 | Stage 5D | 20 (64.5) | 4 (13) | 6 (19.3) | 1 (3.2) | 31 |
| Duration of MHD | | | | | | Less than 6 months | 11 (68.8) | 2 (12.5) | 2 (12.5) | 1 (6.2) | 16 | 6 months to 1 year | 6 (75) | 0 (0) | 2 (25) | 0 (0) | 8 | More than one year | 3 (43) | 2 (28.5) | 2 (28.5) | 0 (0) | 7 |
| Session of MHD per week | | | | | | One | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 1 | Two | 19 (65.5) | 3 (10.4) | 6 (20.7) | 1 (3.4) | 29 | Three | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 |
| History of contact with TB patients | | | | | | Yes | 10 (66.7) | 0 (0) | 3 (20) | 2 (13.3) | 15 | No | 19 (55.8) | 4 (11.8) | 11 (32.4) | 0 (0) | 34 |
| Corticosteroid | | | | | | Yes | 3 (37.5) | 0 (0) | 5 (62.5) | 0 (0) | 8 | No | 26 (63.4) | 4 (9.8) | 9 (22) | 2 (4.8) | 41 |
| Immunosuppressive drugs | | | | | | Yes | 2 (66.7) | 0 (0) | 1 (33.3) | 0 (0) | 3 | No | 27 (58.7) | 4 (8.7) | 13 (28.3) | 2 (4.3) | 46 |
| Diabetes mellitus | | | | | | Yes | 6 (46.2) | 2 (15.4) | 4 (30.8) | 1 (7.6) | 13 | No | 23 (63.9) | 2 (5.6) | 10 (27.8) | 1 (2.7) | 36 |
|
|